2022
DOI: 10.1007/s13577-022-00683-8
|View full text |Cite
|
Sign up to set email alerts
|

SOX9 contributes to the progression of ductular reaction for the protection from chronic liver injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 44 publications
0
1
0
Order By: Relevance
“…In contrast, approximately 10% of patients with BA have a normal gallbladder 55 . A recent study demonstrates the association between intrahepatic SOX9 expression (another SOX factor for cholangiocytes except for the gallbladder walls) and the prognosis in BA 56 . Considering that SOX17-negative (i.e., SOX9+ and/or PDX1+) bile duct progenitors are present in the extrahepatic bile ducts 45 , 46 , 57 , these findings suggest a possible disruption of hepatic and common bile duct walls by the aberrant SOX9+ and/or PDX1+ progenitors in the pathogenesis of other BA groups 10 .…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, approximately 10% of patients with BA have a normal gallbladder 55 . A recent study demonstrates the association between intrahepatic SOX9 expression (another SOX factor for cholangiocytes except for the gallbladder walls) and the prognosis in BA 56 . Considering that SOX17-negative (i.e., SOX9+ and/or PDX1+) bile duct progenitors are present in the extrahepatic bile ducts 45 , 46 , 57 , these findings suggest a possible disruption of hepatic and common bile duct walls by the aberrant SOX9+ and/or PDX1+ progenitors in the pathogenesis of other BA groups 10 .…”
Section: Discussionmentioning
confidence: 99%
“…Although DR’s link to the progression of liver injury is indisputable, the underlying mechanisms of DR remain unclear in patients with BA. 38 43 In preclinical models mimicking BA, blocking Notch signaling decreases cytokeratin-19 expression suggesting that DR arises from hepatic progenitor cells or transdifferentiating hepatocytes instead of self-proliferating cholangiocytes. 8 , 38 , 44 In line with this, PIHs, rather than BE, were increased in follow-up specimens among patients requiring subsequent LT.…”
Section: Discussionmentioning
confidence: 99%
“…Gene set enrichment analysis (GSEA) showed that the genetic markers of HPCs are similar to those of YAP transgenic cells and that YAP activation would lead to their proliferative response 35 . Notably, Sox9 is a downstream target of YAP protein activation and contributes to the progression of the ductal response 82 , which may be the initiating source of YAP-promoted HPCs proliferation. Huh-7 cell models co-expressing Sox9 and YAP show a negative feedback pathway between the two and that Sox9 may inhibit YAP transcription and thus interfere with HPCs.…”
Section: Sox9 Hippo/yap and Notch Signalingmentioning
confidence: 99%